Increased food intake and CCK receptor antagonists: beyond abdominal vagal afferents (Q47606310)

4 February 2018

title

Increased food intake and CCK receptor antagonists: beyond abdominal vagal afferents (English)

1 reference

4 February 2018

author name string

Robert C Ritter

series ordinal

1

1 reference

4 February 2018

publication date

1 June 2004

1 reference

4 February 2018

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

4 February 2018

volume

286

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

R991-3

1 reference

4 February 2018

Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

The effect of centrally administered CCK-receptor antagonists on food intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Increased food intake after type A but not type B cholecystokinin receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Cholecystokinin antibody injected in cerebral ventricles stimulates feeding in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

CholecystokininB receptor antagonist increases food intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Subregional topography of capillaries in the dorsal vagal complex of rats: II. Physiological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Differential Gene Expression of CCK(A) and CCK(B) Receptors in the Rat Brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Role of the calcium-sensing receptor in parathyroid gland physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Endogenous CCK and the peripheral neural substrates of intestinal satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

An intragastric meal releases the putative satiety factor cholecystokinin from hypothalamic neurons in cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Release of hypothalamic cholecystokinin in cats: effects of nutrient and volume loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00116.2004

10.1152/AJPREGU.00116.2004

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15142854

1 reference

4 February 2018